{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:24:10Z","timestamp":1794979450053,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1867-1","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T04:03:42Z","timestamp":1554264222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":197,"title":["Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature"],"prefix":"10.1186","volume":"21","author":[{"given":"M. R.","family":"Pokeerbux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Giovannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Dauchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Agard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Lega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bienvenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Berthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"1867_CR1","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007;66:940\u20134.","journal-title":"Ann Rheum Dis"},{"key":"1867_CR2","doi-asserted-by":"crossref","unstructured":"Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, et AL. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017;76:1897-1905.","DOI":"10.1136\/annrheumdis-2017-211448"},{"key":"1867_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.semarthrit.2008.06.002","volume":"39","author":"FF Al-Dhaher","year":"2010","unstructured":"Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum. 2010;39:269\u201377.","journal-title":"Semin Arthritis Rheum"},{"key":"1867_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/qjmed\/hcp174","volume":"103","author":"SI Nihtyanova","year":"2010","unstructured":"Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. QJM. 2010;103:109\u201315.","journal-title":"QJM."},{"key":"1867_CR5","doi-asserted-by":"crossref","unstructured":"Rubio-Rivas M, Royo C, Sime\u00f3n CP, Corbella X, Fonollosa V. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44:208-19.","DOI":"10.1016\/j.semarthrit.2014.05.010"},{"key":"1867_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","volume":"51","author":"M Elhai","year":"2012","unstructured":"Elhai M, Meune C, Avouac J, Kahan A, Allanore Y. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology. 2012;51:1017\u201326.","journal-title":"Rheumatology."},{"key":"1867_CR7","doi-asserted-by":"crossref","unstructured":"Hao Y, Hudson M, Baron M, Carreira P, Stevens W, Rabusa C, et al. Early mortality in a multinational systemic sclerosis inception cohort. Arthritis Rheumatol. 2017;69:1067-77.","DOI":"10.1002\/art.40027"},{"key":"1867_CR8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.semarthrit.2004.09.001","volume":"34","author":"Y Alamanos","year":"2005","unstructured":"Alamanos Y, Tsifetaki N, Voulgari P, Siozos C, Tsamandouraki K, Alexiou G, et al. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum. 2005;34:714\u201320.","journal-title":"Semin Arthritis Rheum"},{"key":"1867_CR9","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/rheumatology\/35.11.1122","volume":"35","author":"C Bryan","year":"1996","unstructured":"Bryan C, Howard Y, Brennan P, Black CM, Silman A. Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Rheumatology. 1996;35:1122\u20136.","journal-title":"Rheumatology."},{"key":"1867_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.amjmed.2004.04.031","volume":"118","author":"JPA Ioannidis","year":"2005","unstructured":"Ioannidis JPA, Vlachoyiannopoulos PG, Haidich A-B, Medsger TA, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005;118:2\u201310.","journal-title":"Am J Med"},{"key":"1867_CR11","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/rheumatology\/37.7.750","volume":"37","author":"S Jacobsen","year":"1998","unstructured":"Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Rheumatology. 1998;37:750\u20135.","journal-title":"Rheumatology."},{"key":"1867_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/03009742.2011.553736","volume":"40","author":"C-F Kuo","year":"2011","unstructured":"Kuo C-F, See L-C, Yu K-H, Chou I-J, Tseng W-Y, Chang H-C, et al. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol. 2011;40:373\u20138.","journal-title":"Scand J Rheumatol"},{"key":"1867_CR13","first-page":"139","volume":"82","author":"P Lee","year":"1992","unstructured":"Lee P, Langevitz P, Alderdice C, Aubrey M, Baer P, Baron M, et al. Mortality in systemic sclerosis (scleroderma). QJM. 1992;82:139\u201348.","journal-title":"QJM."},{"key":"1867_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","volume":"81","author":"C Ferri","year":"2002","unstructured":"Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore). 2002;81:139\u201353.","journal-title":"Medicine (Baltimore)"},{"key":"1867_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00005792-200203000-00005","volume":"81","author":"L Scussel-Lonzetti","year":"2002","unstructured":"Scussel-Lonzetti L, Joyal F, Raynauld J-P, Roussin A, Rich E, Goulet J-R, et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore). 2002;81:154\u201367.","journal-title":"Medicine (Baltimore)"},{"key":"1867_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/ard.2006.066340","volume":"67","author":"L Czirjak","year":"2008","unstructured":"Czirjak L, Kumanovics G, Varju C, Nagy Z, Pakozdi A, Szekanecz Z, et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis. 2008;67:59\u201363.","journal-title":"Ann Rheum Dis"},{"key":"1867_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/rheumatology\/ken488","volume":"48","author":"E Hachulla","year":"2008","unstructured":"Hachulla E, Carpentier P, Gressin V, Diot E, Allanore Y, Sibilia J, et al. Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study. Rheumatology. 2008;48:304\u20138.","journal-title":"Rheumatology."},{"key":"1867_CR18","doi-asserted-by":"crossref","unstructured":"ssassi S, del Junco D, Sutter K, McNearney TA, Reveille JD, Karnavas A, et al. Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum. 2009;61:1403\u201311.","DOI":"10.1002\/art.24734"},{"key":"1867_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.semarthrit.2009.06.002","volume":"39","author":"BE Joven","year":"2010","unstructured":"Joven BE, Almodovar R, Carmona L, Carreira PE. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. Semin Arthritis Rheum. 2010;39:285\u201393.","journal-title":"Semin Arthritis Rheum"},{"key":"1867_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10067-009-1324-7","volume":"29","author":"J Kim","year":"2010","unstructured":"Kim J, Park SK, Moon KW, Lee EY, Lee YJ, Song YW, et al. The prognostic factors of systemic sclerosis for survival among Koreans. Clin Rheumatol. 2010;29:297\u2013302.","journal-title":"Clin Rheumatol"},{"key":"1867_CR21","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3899\/jrheum.111582","volume":"39","author":"PD Sampaio-Barros","year":"2012","unstructured":"Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG, Rocha LF, Del Rio APT, Samara AM, et al. Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol. 2012;39:1971\u20138.","journal-title":"J Rheumatol"},{"key":"1867_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3899\/jrheum.121390","volume":"40","author":"A-M Hoffmann-Vold","year":"2013","unstructured":"Hoffmann-Vold A-M, Molberg \u00d8, Midtvedt \u00d8, Garen T, Gran JT. Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis. J Rheumatol. 2013;40:1127\u201333.","journal-title":"J Rheumatol"},{"key":"1867_CR23","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s10067-013-2289-0","volume":"32","author":"G Strickland","year":"2013","unstructured":"Strickland G, Pauling J, Cavill C, Shaddick G, McHugh N. Mortality in systemic sclerosis\u2014a single centre study from the UK. Clin Rheumatol. 2013;32:1533\u20139.","journal-title":"Clin Rheumatol"},{"key":"1867_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/MD.0000000000000018","volume":"93","author":"MA Alba","year":"2014","unstructured":"Alba MA, Velasco C, Sime\u00f3n CP, Fonollosa V, Trapiella L, Egurbide MV, et al. Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients. Medicine (Baltimore). 2014;93:73\u201381.","journal-title":"Medicine (Baltimore)"},{"key":"1867_CR25","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/annrheumdis-2012-202849","volume":"73","author":"TR Cottrell","year":"2014","unstructured":"Cottrell TR, Wise RA, Wigley FM, Boin F. The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis. Ann Rheum Dis. 2014;73:1060\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1867_CR26","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/art.38390","volume":"66","author":"SI Nihtyanova","year":"2014","unstructured":"Nihtyanova SI, Schreiber BE, Ong VH, Rosenberg D, Moinzadeh P, Coghlan JG, et al. Prediction of pulmonary complications and long-term survival in systemic sclerosis: pulmonary complications and survival in SSc. Arthritis Rheumatol. 2014;66:1625\u201335.","journal-title":"Arthritis Rheumatol"},{"key":"1867_CR27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/rheumatology\/ker357","volume":"51","author":"A Kom\u00f3csi","year":"2012","unstructured":"Kom\u00f3csi A, Vorobcsuk A, Faludi R, Pint\u00e9r T, Lenkey Z, K\u00f6lt\u0151 G, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology. 2012;51:1027\u201336.","journal-title":"Rheumatology."},{"key":"1867_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","year":"1980","unstructured":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581\u201390.","journal-title":"Arthritis Rheum"},{"key":"1867_CR29","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against rheumatism collaborative initiative: ACR\/EULAR classification criteria for SSc. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"1867_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277\u2013314.","journal-title":"J Am Soc Echocardiogr"},{"key":"1867_CR31","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008\u201312.","journal-title":"JAMA."},{"key":"1867_CR32","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis [internet]. Available from: \n                    http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n                    \n                  ."},{"key":"1867_CR33","first-page":"2100","volume":"22","author":"M Abu-Shakra","year":"1995","unstructured":"Abu-Shakra M, Lee P. Mortality in systemic sclerosis: a comparison with the general population. J Rheumatol. 1995;22:2100\u20132.","journal-title":"J Rheumatol"},{"key":"1867_CR34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s00296-017-3753-y","volume":"37","author":"MP Cruz-Dom\u00ednguez","year":"2017","unstructured":"Cruz-Dom\u00ednguez MP, Garc\u00eda-Collinot G, Saavedra MA, Montes-Cortes DH, Morales-Aguilar R, Carranza-Muleiro RA, et al. Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study. Rheumatol Int. 2017;37:1101\u20139.","journal-title":"Rheumatol Int"},{"key":"1867_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/ard.57.11.682","volume":"57","author":"R Hesselstrand","year":"1998","unstructured":"Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis. 1998;57:682\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1867_CR36","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/art.30277","volume":"63","author":"CC Mok","year":"2011","unstructured":"Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum. 2011;63:1182\u20139.","journal-title":"Arthritis Rheum"},{"key":"1867_CR37","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/rheumatology\/keq046","volume":"49","author":"C Perez-Bocanegra","year":"2010","unstructured":"Perez-Bocanegra C, Solans-Laque R, Simeon-Aznar CP, Campillo M, Fonollosa-Pla V, Vilardell-Tarres M. Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology. 2010;49:1112\u20137.","journal-title":"Rheumatology."},{"key":"1867_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0895-4356(88)90094-7","volume":"41","author":"CJ Zarafonetis","year":"1988","unstructured":"Zarafonetis CJ, Dabich L, Negri D, Skovronski JJ, Devol EB, Wolfe R. Retrospective studies in scleroderma: effect of potassium para-aminobenzoate on survival. J Clin Epidemiol. 1988;41:193\u2013205.","journal-title":"J Clin Epidemiol"},{"key":"1867_CR39","first-page":"S18","volume":"28","author":"L Beretta","year":"2010","unstructured":"Beretta L, Santaniello A, Cappiello F, Chawla NV, Vonk MC, Carreira PE, et al. Development of a five-year mortality model in systemic sclerosis patients by different analytical approaches. Clin Exp Rheumatol. 2010;28:S18.","journal-title":"Clin Exp Rheumatol"},{"key":"1867_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1399-0039.2007.00811.x","volume":"69","author":"L Beretta","year":"2007","unstructured":"Beretta L, Cappiello F, Barili M, Scorza R. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis. Tissue Antigens. 2007;69:305\u201312.","journal-title":"Tissue Antigens"},{"key":"1867_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.autrev.2017.03.012","volume":"16","author":"D Bernal-Bello","year":"2017","unstructured":"Bernal-Bello D, de Tena JG, Guill\u00e9n-del Castillo A, Selva-O\u2019Callaghan A, Callejas-Moraga EL, Mar\u00edn-S\u00e1nchez AM, et al. Novel risk factors related to cancer in scleroderma. Autoimmun Rev. 2017;16:461\u20138.","journal-title":"Autoimmun Rev"},{"key":"1867_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/rheumatology\/kev322","volume":"55","author":"V Codullo","year":"2016","unstructured":"Codullo V, Cereda E, Klersy C, Cavazzana I, Alpini C, Bonardi C, et al. Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients. Rheumatology. 2016;55:315\u20139.","journal-title":"Rheumatology."},{"key":"1867_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00296-015-3382-2","volume":"37","author":"A Fern\u00e1ndez-Codina","year":"2017","unstructured":"Fern\u00e1ndez-Codina A, Sime\u00f3n-Aznar CP, Pinal-Fernandez I, Rodr\u00edguez-Palomares J, Pizzi MN, Hidalgo CE, et al. Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival. Rheumatol Int. 2017;37:75\u201384.","journal-title":"Rheumatol Int"},{"key":"1867_CR44","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.autrev.2014.08.029","volume":"13","author":"C Ferri","year":"2014","unstructured":"Ferri C, Sebastiani M, Lo Monaco A, Iudici M, Giuggioli D, Furini F, et al. Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients\u2019 population and review of the literature. Autoimmun Rev. 2014;13:1026\u201334.","journal-title":"Autoimmun Rev"},{"key":"1867_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/MD.0b013e31829be125","volume":"92","author":"AC Gelber","year":"2013","unstructured":"Gelber AC, Manno RL, Shah AA, Woods A, Le EN, Boin F, et al. Race and association with disease manifestations and mortality in scleroderma. Medicine (Baltimore). 2013;92:191\u2013205.","journal-title":"Medicine (Baltimore)"},{"key":"1867_CR46","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","volume":"42","author":"R Hesselstrand","year":"2003","unstructured":"Hesselstrand R. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology. 2003;42:534\u201340.","journal-title":"Rheumatology."},{"key":"1867_CR47","first-page":"S30","volume":"30","author":"M Hinchcliff","year":"2012","unstructured":"Hinchcliff M, Desai CS, Varga J, Shah SJ. Prevalence, progn,osis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol. 2012;30:S30.","journal-title":"Clin Exp Rheumatol"},{"key":"1867_CR48","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3899\/jrheum.140006","volume":"41","author":"H Hussein","year":"2014","unstructured":"Hussein H, Lee P, Chau C, Johnson SR. The effect of male sex on survival in systemic sclerosis. J Rheumatol. 2014;41:2193\u2013200.","journal-title":"J Rheumatol"},{"key":"1867_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10067-013-2358-4","volume":"33","author":"G K\u00f6lt\u0151","year":"2014","unstructured":"K\u00f6lt\u0151 G, Faludi R, Aradi D, Bartos B, Kum\u00e1novics G, Minier T, et al. Impact of cardiac involvement on the risk of mortality among patients with systemic sclerosis: a 5-year follow-up of a single-center cohort. Clin Rheumatol. 2014;33:197\u2013205.","journal-title":"Clin Rheumatol"},{"key":"1867_CR50","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48:2246\u201355.","journal-title":"Arthritis Rheum"},{"key":"1867_CR51","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00296-016-3475-6","volume":"36","author":"H Poormoghim","year":"2016","unstructured":"Poormoghim H, Andalib E, Jalali A, Ghaderi A, Ghorbannia A, Mojtabavi N. Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran. Rheumatol Int. 2016;36:925\u201334.","journal-title":"Rheumatol Int"},{"key":"1867_CR52","first-page":"1204","volume":"85","author":"S Ruangjutipopan","year":"2002","unstructured":"Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R. Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis. J Med Assoc Thail Chotmaihet Thangphaet. 2002;85:1204\u20139.","journal-title":"J Med Assoc Thail Chotmaihet Thangphaet"},{"key":"1867_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/rheumatology\/keg033","volume":"42","author":"CP Simeon","year":"2003","unstructured":"Simeon CP. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology. 2003;42:71\u20135.","journal-title":"Rheumatology."},{"key":"1867_CR54","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001728","volume":"94","author":"CP Sime\u00f3n-Aznar","year":"2015","unstructured":"Sime\u00f3n-Aznar CP, Fonollosa-Pl\u00e1 V, Tolosa-Vilella C, Espinosa-Garriga G, Campillo-Grau M, Ramos-Casals M, et al. Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death. Medicine (Baltimore). 2015;94:e1728.","journal-title":"Medicine (Baltimore)"},{"key":"1867_CR55","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1002\/art.34482","volume":"64","author":"V Steen","year":"2012","unstructured":"Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. Arthritis Rheum. 2012;64:2986\u201394.","journal-title":"Arthritis Rheum"},{"key":"1867_CR56","doi-asserted-by":"publisher","unstructured":"OECD. \u201cLife expectancy at birth\u201d, in Health at a Glance 2017: OECD Indicators [Internet]. OECD Publishing (Paris); Available from: \n                    https:\/\/doi.org\/10.1787\/health_glance-2017-6-en","DOI":"10.1787\/health_glance-2017-6-en"},{"key":"1867_CR57","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1136\/ard.2010.144360","volume":"70","author":"J Fransen","year":"2011","unstructured":"Fransen J, Popa-Diaconu D, Hesselstrand R, Carreira P, Valentini G, Beretta L, et al. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis. 2011;70:1788\u201392.","journal-title":"Ann Rheum Dis"},{"key":"1867_CR58","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1002\/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N","volume":"42","author":"C Bryan","year":"1999","unstructured":"Bryan C, Knight C, Black CM, Silman AJ. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum. 1999;42:2660\u20135.","journal-title":"Arthritis Rheum"},{"key":"1867_CR59","doi-asserted-by":"crossref","unstructured":"Jouvray M, Launay D, Dubucquoi S, Sobanski V, Podevin C, Lambert M, et al. Whole-body distribution and clinical association of Telangiectases in systemic sclerosis. JAMA Dermatol. 2018;154:796-805.","DOI":"10.1001\/jamadermatol.2018.0916"},{"key":"1867_CR60","doi-asserted-by":"crossref","unstructured":"Sanges S, Giovannelli J, Sobanski V, Morell-Dubois S, Maillard H, Lambert M, et al. Factors associated with the 6-minute walk distance in patients with systemic sclerosis. Arthritis Res Ther. 2017;19:279-90.","DOI":"10.1186\/s13075-017-1489-4"},{"key":"1867_CR61","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/art.38029","volume":"65","author":"G Lef\u00e8vre","year":"2013","unstructured":"Lef\u00e8vre G, Dauchet L, Hachulla E, Montani D, Sobanski V, Lambert M, et al. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum. 2013;65:2412\u201323.","journal-title":"Arthritis Rheum"},{"key":"1867_CR62","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/03009742.2016.1192217","volume":"46","author":"A Nordin","year":"2017","unstructured":"Nordin A, Svenungsson E, Bj\u00f6rn\u00e5dal L, Elvin K, Larsson A, Jensen-Urstad K. Troponin I and echocardiography in patients with systemic sclerosis and matched population controls. Scand J Rheumatol. 2017;46:226\u201335.","journal-title":"Scand J Rheumatol"},{"key":"1867_CR63","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/ard.2006.057760","volume":"67","author":"GP de","year":"2008","unstructured":"de GP, Gressin V, Hachulla E, Carpentier P, Guillevin L, Kahan A, et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis. 2008;67:31\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1867_CR64","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/art.37969","volume":"65","author":"A Onishi","year":"2013","unstructured":"Onishi A, Sugiyama D, Kumagai S, Morinobu A. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum. 2013;65:1913\u201321.","journal-title":"Arthritis Rheum"},{"key":"1867_CR65","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69:1809\u201315.","journal-title":"Ann Rheum Dis"},{"key":"1867_CR66","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/art.27549","volume":"62","author":"AA Shah","year":"2010","unstructured":"Shah AA, Rosen A, Hummers L, Wigley F, Casciola-Rosen L. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I\/III antibodies. Arthritis Rheum. 2010;62:2787\u201395.","journal-title":"Arthritis Rheum"},{"key":"1867_CR67","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S. Adjusting for multiple testing\u2014when and how? J Clin Epidemiol. 2001;54:343\u20139.","journal-title":"J Clin Epidemiol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1867-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1867-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1867-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T19:22:13Z","timestamp":1585768933000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1867-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1867"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1867-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735464002.793568452","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was authorized by the French Ministry of Research. The authorization number is 13145. To issue such authorization, the Ministry of Research has sought the advice of an independent ethics committee, namely the \u201cComit\u00e9 consultatif sur le traitement de l\u2019information en mati\u00e8re de recherche (CCTIRS),\u201d which voted positively. French legislation on non-interventional studies requires collecting the non-opposition of patients but does not require written consent. As such, non-opposition was obtained from each patient included in the study for the use of their de-identified medical record data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"86"}}